A glucose-powered artificial neuroimmune axis for metabolic control
NeuroAxis restores glucose tolerance, improves insulin sensitivity and normalizes glycaemic control, with therapeutic effects persisting after treatment cessation in rat models of type 1 and type 2 diabetes.